FBRX logo

Forte Biosciences, Inc. Stock Price

NasdaqCM:FBRX Community·US$461.8m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 2 Fair Values set on narratives written by author

FBRX Share Price Performance

US$24.86
17.51 (238.23%)
US$24.86
17.51 (238.23%)
Price US$24.86

FBRX Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet with moderate risk.

5 Risks
1 Reward

Forte Biosciences, Inc. Key Details

US$0

Revenue

US$0

Cost of Revenue

US$0

Gross Profit

US$0

Other Expenses

US$0

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
-2.90
0%
0%
0%
View Full Analysis

About FBRX

Founded
n/a
Employees
16
CEO
Paul A. Wagner
WebsiteView website
www.fortebiorx.com

Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. The company’s lead product candidate is the FB-102, a proprietary anti-CD122 monoclonal antibody therapeutic candidate for various autoimmune and autoimmune-related indications, such as graft-vs-host disease, vitiligo, and alopecia areata, as well as for celiac disease and non-segmental vitiligo. Forte Biosciences, Inc. is headquartered in Dallas, Texas.

Recent FBRX News & Updates

We're Not Very Worried About Forte Biosciences' (NASDAQ:FBRX) Cash Burn Rate

Nov 11
We're Not Very Worried About Forte Biosciences' (NASDAQ:FBRX) Cash Burn Rate

Recent updates

No updates